Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis
Background Despite the goal set by WHO to eliminate hepatitis C virus (HCV) as a public
health threat, uptake of HCV testing and treatment remains low. To achieve this target …
health threat, uptake of HCV testing and treatment remains low. To achieve this target …
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
GS Cooke, I Andrieux-Meyer, TL Applegate… - The lancet …, 2019 - thelancet.com
Viral hepatitis is a major public health threat and a leading cause of death worldwide.
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …
[HTML][HTML] Digital health interventions to enhance prevention in primary care: scoping review
VC Willis, KJ Thomas Craig, Y Jabbarpour… - JMIR medical …, 2022 - medinform.jmir.org
Background Disease prevention is a central aspect of primary care practice and is
comprised of primary (eg, vaccinations), secondary (eg, screenings), tertiary (eg, chronic …
comprised of primary (eg, vaccinations), secondary (eg, screenings), tertiary (eg, chronic …
“Beyond MELD”–Emerging strategies and technologies for improving mortality prediction, organ allocation and outcomes in liver transplantation
In this review article, we discuss the model for end-stage liver disease (MELD) score and its
dual purpose in general and transplant hepatology. As the landscape of liver disease and …
dual purpose in general and transplant hepatology. As the landscape of liver disease and …
Health disparities in hepatitis C screening and linkage to care at an integrated health system in southeast Michigan
K Bourgi, I Brar, K Baker-Genaw - PLoS One, 2016 - journals.plos.org
With recommended screening for hepatitis C among the 1945–1965 birth cohort and advent
of novel highly effective therapies, little is known about health disparities in the Hepatitis C …
of novel highly effective therapies, little is known about health disparities in the Hepatitis C …
Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low-and middle-income countries
A Ishizaki, J Bouscaillou, N Luhmann, S Liu… - BMC infectious …, 2017 - Springer
Background There have been few reports on programmatic experience of viral hepatitis
testing and treatment in resource-limited settings. To inform the development of the 2017 …
testing and treatment in resource-limited settings. To inform the development of the 2017 …
[HTML][HTML] How the rural risk environment underpins hepatitis C risk: Qualitative findings from rural southern Illinois, United States
Abstract Background Hepatitis C virus (HCV) infection has increased among persons who
inject drugs (PWID) in the United States with disproportionate burden in rural areas. We use …
inject drugs (PWID) in the United States with disproportionate burden in rural areas. We use …
eHealth technologies for screening, diagnosis, and management of viral hepatitis: a systematic review
J Haridy, G Iyngkaran, A Nicoll, G Hebbard… - Clinical …, 2021 - Elsevier
Background & Aims Chronic viral hepatitis is a leading cause of worldwide liver-related
morbidity and mortality, despite the availability of effective treatments that reduce or prevent …
morbidity and mortality, despite the availability of effective treatments that reduce or prevent …
Predictive factors for not undergoing RNA testing in patients found to have hepatitis C serology and impact of an automatic alert
D Morales‐Arraez, A Alonso‐Larruga… - Journal of Viral …, 2019 - Wiley Online Library
The process of diagnosis and linkage to care in cases of hepatitis C virus (HCV) infection
remains an obstacle to disease control. The aims of this study were to evaluate predictive …
remains an obstacle to disease control. The aims of this study were to evaluate predictive …
Prevalence of Testing for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among Medicaid Enrollees Treated With Medications for Opioid Use …
K Ahrens, M Sharbaugh, MP Jarlenski… - Clinical Infectious …, 2023 - academic.oup.com
Background Limited information exists about testing for human immunodeficiency virus
(HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) among Medicaid enrollees after …
(HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) among Medicaid enrollees after …